logo

For the Inventor, By the Inventor

New Palestine, IN, United States of America

Richard Earl Higgs, Jr

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Earl Higgs, Jr. Retrieved from https://idiyas.com/inventor/richard-earl-higgs-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 87(Granted Patents)


Location History:

  • New Palestine, IN (US) (1999 - 2000)
  • Zionsville, IN (US) (2023)

Company Filing History:

goldMedal4 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 1999-2025

Loading Chart...
4 patents (USPTO):Explore Patents
1. 12459997 - Compounds and methods targeting interleukin-19 (2025-11-04),
2. 11591387 - Compounds and methods targeting interleukin-19 (2023-02-28),
3. 6021213 - Automatic contextual segmentation for imaging bones for osteoporosis (2000-02-01),
4. 5885841 - System and methods for qualitatively and quantitatively comparing (1999-03-23),

Title: Richard Earl Higgs, Jr.: Innovator in Immune-Mediated Disease Therapies

Introduction

Richard Earl Higgs, Jr. is a notable inventor based in New Palestine, IN (US). He has made significant contributions to the field of immunology, particularly in developing therapies for immune-mediated diseases. With a total of 4 patents, Higgs has focused on innovative solutions that target specific interleukins.

Latest Patents

Higgs' latest patents include groundbreaking work on compounds and methods targeting human interleukin-19. These inventions encompass therapeutic antibodies, pharmaceutical compositions, and diagnostic applications. They are particularly useful in treating immune-mediated diseases such as psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma, and diabetic nephropathy.

Career Highlights

Richard Higgs is currently associated with Eli Lilly and Company, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from various immune-related conditions.

Collaborations

Higgs has collaborated with esteemed colleagues, including Robert John Konrad and Brian Jeffrey Nickoloff. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the medical field.

Conclusion

Richard Earl Higgs, Jr. stands out as a dedicated inventor whose work in targeting interleukin-19 has the potential to transform treatments for immune-mediated diseases. His contributions to the field are invaluable and continue to pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…